Fos Overexpression Is Associated with the Pathoneogenesis of Invasive Cervical Cancer

Gynecologic and Obstetric Investigation

Volumn 43, Issue 3, 1997, Pages 200-203

  Cheung, T H ^a   Leung, J O ^a   Chung, Tony K H ^a   Lam, S K ^a   To, K F ^a   Wong, Y F ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cervical cancer; Fos overexpression

Indexed keywords

ONCOPROTEIN;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE C FOS; PATHOGENESIS; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENE EXPRESSION; GENES, FOS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-FOS; UTERINE CERVICAL NEOPLASMS;

EID: 0030951526     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000291854     Document Type: Article

References (17)

1. Bishop JM: Molecular themes in oncogenesis. Cells 1991;64:235-248.
2. Nürnberg W, Artuc M, Vorbrucggcn G. Kalk-brenner F, Moelling K, Czarnetzki BM. Schadendorf D: Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter. Br J Cancer 1995;71:1018-1024.
3. Rauscher FJ III, Cohen DR, Curran T, et al: Fos-associated protein p39 is the product of the jun proto-oncogene. Science 1988:240:1010-1016.
4. Monnat M, Tardy S, Saraga P, Diggelmann H, Costa J: Prognostic implications of expression of the cellular genes. Myc, fos, Ha-ra.v and Kiras in colon carcinoma. Int J Cancer 1987;40: 293-299.
5. Walker RA, Cow J: The expression of c-fos protein in human breast. J Pathol 1991; 163:323-327.
6. Taniguchi S. Kawano T, Mitsudomi T. Kimura G. Baba T: Fos oncogene transfer to a transformed rat fibroblast cell line enhances spontaneous lung metastasis in rat. Jpn J Cancer Res 1986;77:1193-1197.
7. Biland K, Konstandoulakis MM, Vezeridis MP, Wanebo HJ: Oncogene protein co-expression. Ann Surg 1995;221:706-720.
8. Varmus H: An histological overview of oncogenes; in Weinberg RA (ed): Oncogenes and the Molecular Origins of Cancer. Plainview, Cold Spring Harbor Laboratory Press, 1989, p 67.
9. MacKay SLD, Bennett NT, Bland KI, et al: Growth factors, tumor suppressors, and cancer. Perspect Gen Surg 1991;3:1-62.
10. Wu JX, Carpenter PM, Grescns C, Kch R, Niman H, Morris JW. Mercola D: The protooncogene c-fos is over-expressed in the majority of human osteocarcomas. Oncogene 1990:5: 898-1000.
11. Arbuthnot P, Kew M, Fitshen W: c-fos and c-myc expression in human hepatocellular carcinomas. Anticancer Res 1991:11:921-924.
12. Magrisso IJ, Richmond RE, Carter JH, Pross CB, Grifillen RA, Carter HW: Immunohistochemical detection of ras, jun, fos and p53 oncoprotein expression in human colorectal adenomas and carcinomas. Lab Invest 1993; 69:674-681.
13. Volm M, Drings P, Wodrich W: Prognostic significance of the expression of c-fos, c-jun and c-eriB-1 oncogene products in human squamous cell lung carcinomas. J Cancer Res Clin Oncol 1993;119:507-510.
14. Volm M, Efferth T, Mattcm J: Oncoprotein (c-myc, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of lung: clinical and biological correlations. Anticancer Res 1992; 12:11-20.
15. Walk RA. Cowl J: The expression of c-fos protein in human breast. J Pathol 1991; 163:323-327.
16. Petrov SV, Mazurenko NN, Sukhova NM, Moroz IP. Katsenel’son VM, Raikhlin MT, Kiselev FL: Cell oncogene expression in normal, metaplastic, dysplastic epithelium and squamous cell carcinoma of the uterine cervix. Arkh Pathol 1994;56:22-31.
17. Matrisian LM, Bowden GT, Krieg P, et al: The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumours. Proc Natl Acad Sci USA 1986;83:9413-9417.